Observation for Patients With Asymptomatic CNS Metastatic Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 1, 2017

Study Completion Date

December 1, 2017

Conditions
CancerMetastatic Cancer
Interventions
OTHER

Observation

Trial Locations (1)

08103

Cooper University Hospital, Camden

All Listed Sponsors
lead

The Cooper Health System

OTHER

NCT02866981 - Observation for Patients With Asymptomatic CNS Metastatic Disease | Biotech Hunter | Biotech Hunter